nodes	percent_of_prediction	percent_of_DWPC	metapath
Riluzole—SCN5A—dilated cardiomyopathy	0.792	1	CbGaD
Riluzole—SCN5A—purkinje fiber—dilated cardiomyopathy	0.0474	0.453	CbGeAlD
Riluzole—SCN5A—endocardium—dilated cardiomyopathy	0.0244	0.233	CbGeAlD
Riluzole—SCN5A—sinoatrial node—dilated cardiomyopathy	0.0231	0.221	CbGeAlD
Riluzole—SCN5A—cardiac ventricle—dilated cardiomyopathy	0.00205	0.0197	CbGeAlD
Riluzole—SCN5A—myocardium—dilated cardiomyopathy	0.00193	0.0185	CbGeAlD
Riluzole—SCN5A—heart—dilated cardiomyopathy	0.00135	0.0129	CbGeAlD
Riluzole—SCN5A—cardiac atrium—dilated cardiomyopathy	0.00115	0.011	CbGeAlD
Riluzole—CYP1A1—cardiac ventricle—dilated cardiomyopathy	0.00107	0.0102	CbGeAlD
Riluzole—Renal pain—Lisinopril—dilated cardiomyopathy	0.00105	0.0105	CcSEcCtD
Riluzole—Thrombosis—Furosemide—dilated cardiomyopathy	0.00104	0.0104	CcSEcCtD
Riluzole—Apathy—Furosemide—dilated cardiomyopathy	0.00103	0.0103	CcSEcCtD
Riluzole—Flat affect—Furosemide—dilated cardiomyopathy	0.00103	0.0102	CcSEcCtD
Riluzole—Generalised oedema—Lisinopril—dilated cardiomyopathy	0.000932	0.00924	CcSEcCtD
Riluzole—Ataxia—Spironolactone—dilated cardiomyopathy	0.000927	0.00919	CcSEcCtD
Riluzole—Nephrolithiasis—Furosemide—dilated cardiomyopathy	0.000919	0.00911	CcSEcCtD
Riluzole—Glycosuria—Furosemide—dilated cardiomyopathy	0.000912	0.00904	CcSEcCtD
Riluzole—Psoriasis—Lisinopril—dilated cardiomyopathy	0.000882	0.00874	CcSEcCtD
Riluzole—Gastritis—Spironolactone—dilated cardiomyopathy	0.000873	0.00865	CcSEcCtD
Riluzole—Gout—Furosemide—dilated cardiomyopathy	0.000791	0.00785	CcSEcCtD
Riluzole—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.000785	0.00778	CcSEcCtD
Riluzole—Laryngitis—Lisinopril—dilated cardiomyopathy	0.000769	0.00763	CcSEcCtD
Riluzole—Haemoptysis—Lisinopril—dilated cardiomyopathy	0.000749	0.00743	CcSEcCtD
Riluzole—ABCG2—heart—dilated cardiomyopathy	0.000738	0.00706	CbGeAlD
Riluzole—Pleural effusion—Lisinopril—dilated cardiomyopathy	0.000724	0.00718	CcSEcCtD
Riluzole—Ventricular fibrillation—Lisinopril—dilated cardiomyopathy	0.000724	0.00718	CcSEcCtD
Riluzole—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.000709	0.00703	CcSEcCtD
Riluzole—CYP1A1—heart—dilated cardiomyopathy	0.0007	0.0067	CbGeAlD
Riluzole—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.000694	0.00688	CcSEcCtD
Riluzole—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.000679	0.00673	CcSEcCtD
Riluzole—Endocrine disorder—Lisinopril—dilated cardiomyopathy	0.000669	0.00663	CcSEcCtD
Riluzole—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.000645	0.00639	CcSEcCtD
Riluzole—Mental disability—Furosemide—dilated cardiomyopathy	0.000641	0.00636	CcSEcCtD
Riluzole—Breast pain—Lisinopril—dilated cardiomyopathy	0.000636	0.0063	CcSEcCtD
Riluzole—Accidental injury—Lisinopril—dilated cardiomyopathy	0.000627	0.00621	CcSEcCtD
Riluzole—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.000617	0.00611	CcSEcCtD
Riluzole—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.000614	0.00609	CcSEcCtD
Riluzole—Photosensitivity—Furosemide—dilated cardiomyopathy	0.000611	0.00606	CcSEcCtD
Riluzole—Arthropathy—Lisinopril—dilated cardiomyopathy	0.00061	0.00604	CcSEcCtD
Riluzole—Cough increased—Lisinopril—dilated cardiomyopathy	0.000606	0.006	CcSEcCtD
Riluzole—Alopecia—Spironolactone—dilated cardiomyopathy	0.000603	0.00598	CcSEcCtD
Riluzole—Vascular purpura—Furosemide—dilated cardiomyopathy	0.0006	0.00594	CcSEcCtD
Riluzole—Deafness—Furosemide—dilated cardiomyopathy	0.0006	0.00594	CcSEcCtD
Riluzole—CYP1A1—cardiac atrium—dilated cardiomyopathy	0.000599	0.00573	CbGeAlD
Riluzole—Gout—Lisinopril—dilated cardiomyopathy	0.000594	0.00589	CcSEcCtD
Riluzole—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.00059	0.00585	CcSEcCtD
Riluzole—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.000571	0.00566	CcSEcCtD
Riluzole—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.000569	0.00564	CcSEcCtD
Riluzole—Thirst—Furosemide—dilated cardiomyopathy	0.000564	0.00559	CcSEcCtD
Riluzole—Neck pain—Lisinopril—dilated cardiomyopathy	0.000561	0.00556	CcSEcCtD
Riluzole—Purpura—Furosemide—dilated cardiomyopathy	0.000557	0.00552	CcSEcCtD
Riluzole—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.000555	0.0055	CcSEcCtD
Riluzole—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.000555	0.0055	CcSEcCtD
Riluzole—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.000554	0.00549	CcSEcCtD
Riluzole—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.000551	0.00546	CcSEcCtD
Riluzole—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.000539	0.00534	CcSEcCtD
Riluzole—Malaise—Spironolactone—dilated cardiomyopathy	0.000536	0.00531	CcSEcCtD
Riluzole—Leukopenia—Spironolactone—dilated cardiomyopathy	0.000532	0.00527	CcSEcCtD
Riluzole—Fluid retention—Lisinopril—dilated cardiomyopathy	0.000526	0.00522	CcSEcCtD
Riluzole—Photophobia—Lisinopril—dilated cardiomyopathy	0.000521	0.00516	CcSEcCtD
Riluzole—Urinary retention—Furosemide—dilated cardiomyopathy	0.00051	0.00506	CcSEcCtD
Riluzole—Discomfort—Spironolactone—dilated cardiomyopathy	0.000499	0.00495	CcSEcCtD
Riluzole—Dehydration—Furosemide—dilated cardiomyopathy	0.000499	0.00495	CcSEcCtD
Riluzole—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.000494	0.00489	CcSEcCtD
Riluzole—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00049	0.00486	CcSEcCtD
Riluzole—Confusional state—Spironolactone—dilated cardiomyopathy	0.000489	0.00484	CcSEcCtD
Riluzole—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.000488	0.00484	CcSEcCtD
Riluzole—Hypertonia—Lisinopril—dilated cardiomyopathy	0.000486	0.00482	CcSEcCtD
Riluzole—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.000485	0.0048	CcSEcCtD
Riluzole—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000475	0.0047	CcSEcCtD
Riluzole—Muscular weakness—Furosemide—dilated cardiomyopathy	0.000473	0.00469	CcSEcCtD
Riluzole—Abdominal distension—Furosemide—dilated cardiomyopathy	0.000467	0.00463	CcSEcCtD
Riluzole—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.000463	0.00459	CcSEcCtD
Riluzole—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.000461	0.00457	CcSEcCtD
Riluzole—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.000458	0.00454	CcSEcCtD
Riluzole—Pancreatitis—Furosemide—dilated cardiomyopathy	0.000455	0.00451	CcSEcCtD
Riluzole—Eczema—Lisinopril—dilated cardiomyopathy	0.000448	0.00444	CcSEcCtD
Riluzole—Injury—Lisinopril—dilated cardiomyopathy	0.000438	0.00434	CcSEcCtD
Riluzole—Libido decreased—Lisinopril—dilated cardiomyopathy	0.000434	0.0043	CcSEcCtD
Riluzole—Somnolence—Spironolactone—dilated cardiomyopathy	0.000431	0.00427	CcSEcCtD
Riluzole—Pollakiuria—Furosemide—dilated cardiomyopathy	0.000428	0.00425	CcSEcCtD
Riluzole—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.000425	0.00421	CcSEcCtD
Riluzole—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.000423	0.0042	CcSEcCtD
Riluzole—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000418	0.00415	CcSEcCtD
Riluzole—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.000416	0.00412	CcSEcCtD
Riluzole—Arthritis—Lisinopril—dilated cardiomyopathy	0.000414	0.00411	CcSEcCtD
Riluzole—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.000404	0.00401	CcSEcCtD
Riluzole—Diplopia—Lisinopril—dilated cardiomyopathy	0.000403	0.00399	CcSEcCtD
Riluzole—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.000403	0.00399	CcSEcCtD
Riluzole—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000399	0.00396	CcSEcCtD
Riluzole—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.000399	0.00396	CcSEcCtD
Riluzole—Sweating—Furosemide—dilated cardiomyopathy	0.000396	0.00393	CcSEcCtD
Riluzole—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.000391	0.00388	CcSEcCtD
Riluzole—Face oedema—Lisinopril—dilated cardiomyopathy	0.000389	0.00385	CcSEcCtD
Riluzole—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000386	0.00382	CcSEcCtD
Riluzole—Urticaria—Spironolactone—dilated cardiomyopathy	0.000385	0.00382	CcSEcCtD
Riluzole—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000383	0.0038	CcSEcCtD
Riluzole—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.000383	0.00379	CcSEcCtD
Riluzole—Ataxia—Lisinopril—dilated cardiomyopathy	0.000378	0.00375	CcSEcCtD
Riluzole—Dehydration—Lisinopril—dilated cardiomyopathy	0.000374	0.00371	CcSEcCtD
Riluzole—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.000368	0.00364	CcSEcCtD
Riluzole—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.000367	0.00363	CcSEcCtD
Riluzole—Urethral disorder—Furosemide—dilated cardiomyopathy	0.000364	0.00361	CcSEcCtD
Riluzole—Breast disorder—Lisinopril—dilated cardiomyopathy	0.000364	0.00361	CcSEcCtD
Riluzole—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000357	0.00354	CcSEcCtD
Riluzole—Gastritis—Lisinopril—dilated cardiomyopathy	0.000356	0.00353	CcSEcCtD
Riluzole—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.000351	0.00348	CcSEcCtD
Riluzole—Influenza—Lisinopril—dilated cardiomyopathy	0.000348	0.00345	CcSEcCtD
Riluzole—Asthma—Lisinopril—dilated cardiomyopathy	0.000348	0.00345	CcSEcCtD
Riluzole—Eye disorder—Furosemide—dilated cardiomyopathy	0.000347	0.00344	CcSEcCtD
Riluzole—Pruritus—Spironolactone—dilated cardiomyopathy	0.000343	0.0034	CcSEcCtD
Riluzole—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.000341	0.00338	CcSEcCtD
Riluzole—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.000339	0.00336	CcSEcCtD
Riluzole—Angiopathy—Furosemide—dilated cardiomyopathy	0.000337	0.00334	CcSEcCtD
Riluzole—Immune system disorder—Furosemide—dilated cardiomyopathy	0.000335	0.00332	CcSEcCtD
Riluzole—Bronchitis—Lisinopril—dilated cardiomyopathy	0.000335	0.00332	CcSEcCtD
Riluzole—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000332	0.00329	CcSEcCtD
Riluzole—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000332	0.00329	CcSEcCtD
Riluzole—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.00033	0.00328	CcSEcCtD
Riluzole—Neutropenia—Lisinopril—dilated cardiomyopathy	0.000325	0.00322	CcSEcCtD
Riluzole—Dysuria—Lisinopril—dilated cardiomyopathy	0.000325	0.00322	CcSEcCtD
Riluzole—Malnutrition—Furosemide—dilated cardiomyopathy	0.000323	0.0032	CcSEcCtD
Riluzole—Dizziness—Spironolactone—dilated cardiomyopathy	0.00032	0.00318	CcSEcCtD
Riluzole—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00032	0.00318	CcSEcCtD
Riluzole—Flatulence—Furosemide—dilated cardiomyopathy	0.000318	0.00316	CcSEcCtD
Riluzole—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.000318	0.00315	CcSEcCtD
Riluzole—Weight increased—Lisinopril—dilated cardiomyopathy	0.000317	0.00314	CcSEcCtD
Riluzole—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000316	0.00314	CcSEcCtD
Riluzole—Weight decreased—Lisinopril—dilated cardiomyopathy	0.000315	0.00312	CcSEcCtD
Riluzole—Pneumonia—Lisinopril—dilated cardiomyopathy	0.000312	0.00309	CcSEcCtD
Riluzole—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000311	0.00308	CcSEcCtD
Riluzole—Depression—Lisinopril—dilated cardiomyopathy	0.000309	0.00307	CcSEcCtD
Riluzole—Vomiting—Spironolactone—dilated cardiomyopathy	0.000308	0.00305	CcSEcCtD
Riluzole—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.000306	0.00303	CcSEcCtD
Riluzole—Rash—Spironolactone—dilated cardiomyopathy	0.000306	0.00303	CcSEcCtD
Riluzole—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000305	0.00303	CcSEcCtD
Riluzole—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.000304	0.00301	CcSEcCtD
Riluzole—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.000304	0.00301	CcSEcCtD
Riluzole—Headache—Spironolactone—dilated cardiomyopathy	0.000304	0.00301	CcSEcCtD
Riluzole—Jaundice—Lisinopril—dilated cardiomyopathy	0.000302	0.003	CcSEcCtD
Riluzole—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.000302	0.00299	CcSEcCtD
Riluzole—Anaemia—Furosemide—dilated cardiomyopathy	0.000299	0.00296	CcSEcCtD
Riluzole—Sweating—Lisinopril—dilated cardiomyopathy	0.000297	0.00295	CcSEcCtD
Riluzole—Agitation—Furosemide—dilated cardiomyopathy	0.000297	0.00294	CcSEcCtD
Riluzole—Haematuria—Lisinopril—dilated cardiomyopathy	0.000296	0.00293	CcSEcCtD
Riluzole—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.000293	0.00291	CcSEcCtD
Riluzole—Epistaxis—Lisinopril—dilated cardiomyopathy	0.000293	0.0029	CcSEcCtD
Riluzole—Sinusitis—Lisinopril—dilated cardiomyopathy	0.000291	0.00288	CcSEcCtD
Riluzole—Vertigo—Furosemide—dilated cardiomyopathy	0.00029	0.00288	CcSEcCtD
Riluzole—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000289	0.00287	CcSEcCtD
Riluzole—Leukopenia—Furosemide—dilated cardiomyopathy	0.000289	0.00287	CcSEcCtD
Riluzole—Nausea—Spironolactone—dilated cardiomyopathy	0.000288	0.00285	CcSEcCtD
Riluzole—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000283	0.00281	CcSEcCtD
Riluzole—Rhinitis—Lisinopril—dilated cardiomyopathy	0.000279	0.00277	CcSEcCtD
Riluzole—Hepatitis—Lisinopril—dilated cardiomyopathy	0.000278	0.00276	CcSEcCtD
Riluzole—Hallucination—Lisinopril—dilated cardiomyopathy	0.000277	0.00275	CcSEcCtD
Riluzole—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.000276	0.00274	CcSEcCtD
Riluzole—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.000275	0.00273	CcSEcCtD
Riluzole—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.000274	0.00272	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000273	0.00271	CcSEcCtD
Riluzole—SCN5A—Cardiac Progenitor Differentiation—MYH6—dilated cardiomyopathy	0.000273	0.091	CbGpPWpGaD
Riluzole—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.000273	0.00271	CcSEcCtD
Riluzole—Dry mouth—Furosemide—dilated cardiomyopathy	0.000269	0.00267	CcSEcCtD
Riluzole—Confusional state—Furosemide—dilated cardiomyopathy	0.000266	0.00264	CcSEcCtD
Riluzole—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000264	0.00261	CcSEcCtD
Riluzole—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000263	0.00261	CcSEcCtD
Riluzole—Shock—Furosemide—dilated cardiomyopathy	0.000259	0.00257	CcSEcCtD
Riluzole—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000259	0.00256	CcSEcCtD
Riluzole—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000258	0.00256	CcSEcCtD
Riluzole—Skin disorder—Furosemide—dilated cardiomyopathy	0.000256	0.00254	CcSEcCtD
Riluzole—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000255	0.00253	CcSEcCtD
Riluzole—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000253	0.0025	CcSEcCtD
Riluzole—Anorexia—Furosemide—dilated cardiomyopathy	0.000251	0.00249	CcSEcCtD
Riluzole—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000251	0.00249	CcSEcCtD
Riluzole—Chills—Lisinopril—dilated cardiomyopathy	0.00025	0.00248	CcSEcCtD
Riluzole—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000249	0.00247	CcSEcCtD
Riluzole—Hypotension—Furosemide—dilated cardiomyopathy	0.000246	0.00244	CcSEcCtD
Riluzole—Alopecia—Lisinopril—dilated cardiomyopathy	0.000246	0.00244	CcSEcCtD
Riluzole—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000244	0.00242	CcSEcCtD
Riluzole—SCN5A—Cardiac Progenitor Differentiation—TNNI3—dilated cardiomyopathy	0.000243	0.0811	CbGpPWpGaD
Riluzole—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000242	0.0024	CcSEcCtD
Riluzole—Flatulence—Lisinopril—dilated cardiomyopathy	0.000239	0.00237	CcSEcCtD
Riluzole—Tension—Lisinopril—dilated cardiomyopathy	0.000238	0.00236	CcSEcCtD
Riluzole—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000237	0.00235	CcSEcCtD
Riluzole—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000237	0.00235	CcSEcCtD
Riluzole—Nervousness—Lisinopril—dilated cardiomyopathy	0.000235	0.00233	CcSEcCtD
Riluzole—Back pain—Lisinopril—dilated cardiomyopathy	0.000234	0.00232	CcSEcCtD
Riluzole—Somnolence—Furosemide—dilated cardiomyopathy	0.000234	0.00232	CcSEcCtD
Riluzole—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000233	0.00231	CcSEcCtD
Riluzole—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000229	0.00227	CcSEcCtD
Riluzole—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000228	0.00226	CcSEcCtD
Riluzole—Fatigue—Furosemide—dilated cardiomyopathy	0.000227	0.00225	CcSEcCtD
Riluzole—Tremor—Lisinopril—dilated cardiomyopathy	0.000227	0.00225	CcSEcCtD
Riluzole—Pain—Furosemide—dilated cardiomyopathy	0.000225	0.00224	CcSEcCtD
Riluzole—Constipation—Furosemide—dilated cardiomyopathy	0.000225	0.00224	CcSEcCtD
Riluzole—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000225	0.00223	CcSEcCtD
Riluzole—Anaemia—Lisinopril—dilated cardiomyopathy	0.000224	0.00222	CcSEcCtD
Riluzole—SLC7A11—Basigin interactions—ITGB1—dilated cardiomyopathy	0.000222	0.0739	CbGpPWpGaD
Riluzole—Angioedema—Lisinopril—dilated cardiomyopathy	0.000221	0.0022	CcSEcCtD
Riluzole—Malaise—Lisinopril—dilated cardiomyopathy	0.000219	0.00217	CcSEcCtD
Riluzole—Vertigo—Lisinopril—dilated cardiomyopathy	0.000218	0.00216	CcSEcCtD
Riluzole—Syncope—Lisinopril—dilated cardiomyopathy	0.000217	0.00215	CcSEcCtD
Riluzole—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000217	0.00215	CcSEcCtD
Riluzole—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000217	0.00215	CcSEcCtD
Riluzole—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000216	0.00214	CcSEcCtD
Riluzole—Palpitations—Lisinopril—dilated cardiomyopathy	0.000214	0.00212	CcSEcCtD
Riluzole—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000213	0.00211	CcSEcCtD
Riluzole—Cough—Lisinopril—dilated cardiomyopathy	0.000212	0.0021	CcSEcCtD
Riluzole—Urticaria—Furosemide—dilated cardiomyopathy	0.000209	0.00208	CcSEcCtD
Riluzole—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000208	0.00207	CcSEcCtD
Riluzole—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000208	0.00207	CcSEcCtD
Riluzole—SCN5A—Cardiac Progenitor Differentiation—ACTC1—dilated cardiomyopathy	0.000207	0.0689	CbGpPWpGaD
Riluzole—SCN5A—Cardiac Progenitor Differentiation—TNNT2—dilated cardiomyopathy	0.000207	0.0689	CbGpPWpGaD
Riluzole—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000206	0.00205	CcSEcCtD
Riluzole—Myalgia—Lisinopril—dilated cardiomyopathy	0.000206	0.00205	CcSEcCtD
Riluzole—Chest pain—Lisinopril—dilated cardiomyopathy	0.000206	0.00205	CcSEcCtD
Riluzole—Anxiety—Lisinopril—dilated cardiomyopathy	0.000206	0.00204	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000205	0.00203	CcSEcCtD
Riluzole—Discomfort—Lisinopril—dilated cardiomyopathy	0.000204	0.00202	CcSEcCtD
Riluzole—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000202	0.002	CcSEcCtD
Riluzole—Confusional state—Lisinopril—dilated cardiomyopathy	0.000199	0.00198	CcSEcCtD
Riluzole—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000198	0.00196	CcSEcCtD
Riluzole—Oedema—Lisinopril—dilated cardiomyopathy	0.000198	0.00196	CcSEcCtD
Riluzole—Infection—Lisinopril—dilated cardiomyopathy	0.000197	0.00195	CcSEcCtD
Riluzole—Shock—Lisinopril—dilated cardiomyopathy	0.000195	0.00193	CcSEcCtD
Riluzole—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000194	0.00193	CcSEcCtD
Riluzole—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000194	0.00192	CcSEcCtD
Riluzole—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000193	0.00191	CcSEcCtD
Riluzole—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000192	0.0019	CcSEcCtD
Riluzole—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000191	0.0019	CcSEcCtD
Riluzole—Asthenia—Furosemide—dilated cardiomyopathy	0.000189	0.00188	CcSEcCtD
Riluzole—Anorexia—Lisinopril—dilated cardiomyopathy	0.000189	0.00187	CcSEcCtD
Riluzole—Pruritus—Furosemide—dilated cardiomyopathy	0.000187	0.00185	CcSEcCtD
Riluzole—Hypotension—Lisinopril—dilated cardiomyopathy	0.000185	0.00183	CcSEcCtD
Riluzole—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00018	0.00179	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00018	0.00179	CcSEcCtD
Riluzole—Insomnia—Lisinopril—dilated cardiomyopathy	0.000179	0.00177	CcSEcCtD
Riluzole—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000178	0.00176	CcSEcCtD
Riluzole—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000176	0.00175	CcSEcCtD
Riluzole—Somnolence—Lisinopril—dilated cardiomyopathy	0.000176	0.00174	CcSEcCtD
Riluzole—Dizziness—Furosemide—dilated cardiomyopathy	0.000174	0.00173	CcSEcCtD
Riluzole—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000174	0.00173	CcSEcCtD
Riluzole—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000172	0.0017	CcSEcCtD
Riluzole—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000171	0.00169	CcSEcCtD
Riluzole—Fatigue—Lisinopril—dilated cardiomyopathy	0.000171	0.00169	CcSEcCtD
Riluzole—Constipation—Lisinopril—dilated cardiomyopathy	0.000169	0.00168	CcSEcCtD
Riluzole—Pain—Lisinopril—dilated cardiomyopathy	0.000169	0.00168	CcSEcCtD
Riluzole—Vomiting—Furosemide—dilated cardiomyopathy	0.000168	0.00166	CcSEcCtD
Riluzole—Rash—Furosemide—dilated cardiomyopathy	0.000166	0.00165	CcSEcCtD
Riluzole—Dermatitis—Furosemide—dilated cardiomyopathy	0.000166	0.00165	CcSEcCtD
Riluzole—Headache—Furosemide—dilated cardiomyopathy	0.000165	0.00164	CcSEcCtD
Riluzole—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000163	0.00162	CcSEcCtD
Riluzole—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000162	0.0016	CcSEcCtD
Riluzole—Urticaria—Lisinopril—dilated cardiomyopathy	0.000157	0.00156	CcSEcCtD
Riluzole—Nausea—Furosemide—dilated cardiomyopathy	0.000157	0.00155	CcSEcCtD
Riluzole—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000156	0.00155	CcSEcCtD
Riluzole—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000156	0.00155	CcSEcCtD
Riluzole—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000146	0.00144	CcSEcCtD
Riluzole—Asthenia—Lisinopril—dilated cardiomyopathy	0.000142	0.00141	CcSEcCtD
Riluzole—Pruritus—Lisinopril—dilated cardiomyopathy	0.00014	0.00139	CcSEcCtD
Riluzole—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000135	0.00134	CcSEcCtD
Riluzole—Dizziness—Lisinopril—dilated cardiomyopathy	0.000131	0.0013	CcSEcCtD
Riluzole—Vomiting—Lisinopril—dilated cardiomyopathy	0.000126	0.00125	CcSEcCtD
Riluzole—Rash—Lisinopril—dilated cardiomyopathy	0.000125	0.00124	CcSEcCtD
Riluzole—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000125	0.00124	CcSEcCtD
Riluzole—Headache—Lisinopril—dilated cardiomyopathy	0.000124	0.00123	CcSEcCtD
Riluzole—Nausea—Lisinopril—dilated cardiomyopathy	0.000118	0.00116	CcSEcCtD
Riluzole—SLC7A11—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	8.95e-05	0.0298	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	8.21e-05	0.0273	CbGpPWpGaD
Riluzole—SLC7A11—Cell surface interactions at the vascular wall—ITGB1—dilated cardiomyopathy	7.37e-05	0.0246	CbGpPWpGaD
Riluzole—CYP1A1—PPARA activates gene expression—ANKRD1—dilated cardiomyopathy	6.3e-05	0.021	CbGpPWpGaD
Riluzole—CYP1A1—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	6.17e-05	0.0205	CbGpPWpGaD
Riluzole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ANKRD1—dilated cardiomyopathy	6.17e-05	0.0205	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—ZIC3—dilated cardiomyopathy	6.04e-05	0.0201	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—TTN—dilated cardiomyopathy	5.4e-05	0.018	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—ACTN2—dilated cardiomyopathy	4.68e-05	0.0156	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	4.68e-05	0.0156	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	4.55e-05	0.0152	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	4.55e-05	0.0152	CbGpPWpGaD
Riluzole—SCN5A—L1CAM interactions—ITGB1—dilated cardiomyopathy	4.48e-05	0.0149	CbGpPWpGaD
Riluzole—CYP1A1—Oxidative Stress—SOD2—dilated cardiomyopathy	4.31e-05	0.0144	CbGpPWpGaD
Riluzole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—ANKRD1—dilated cardiomyopathy	4.25e-05	0.0142	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	4.23e-05	0.0141	CbGpPWpGaD
Riluzole—CYP1A1—Oxidative Stress—GPX1—dilated cardiomyopathy	4.12e-05	0.0137	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—VCL—dilated cardiomyopathy	3.98e-05	0.0133	CbGpPWpGaD
Riluzole—CYP1A2—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	3.93e-05	0.0131	CbGpPWpGaD
Riluzole—SCN5A—L1CAM interactions—RAC1—dilated cardiomyopathy	3.6e-05	0.012	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	3.2e-05	0.0107	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	2.85e-05	0.00948	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	2.78e-05	0.00925	CbGpPWpGaD
Riluzole—CYP1A1—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	2.73e-05	0.00911	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—PSEN2—dilated cardiomyopathy	2.71e-05	0.00901	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—ITGB1—dilated cardiomyopathy	2e-05	0.00666	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—PSEN2—dilated cardiomyopathy	1.93e-05	0.00643	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	1.82e-05	0.00605	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	1.78e-05	0.00593	CbGpPWpGaD
Riluzole—CYP1A2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	1.74e-05	0.00581	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—CD36—dilated cardiomyopathy	1.71e-05	0.00568	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	1.69e-05	0.00564	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—ITGB1—dilated cardiomyopathy	1.69e-05	0.00564	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	1.69e-05	0.00564	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	1.65e-05	0.00549	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	1.65e-05	0.00549	CbGpPWpGaD
Riluzole—SCN5A—L1CAM interactions—EGFR—dilated cardiomyopathy	1.64e-05	0.00545	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—RAC1—dilated cardiomyopathy	1.61e-05	0.00535	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	1.59e-05	0.0053	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	1.53e-05	0.0051	CbGpPWpGaD
Riluzole—CYP1A1—PPARA activates gene expression—CD36—dilated cardiomyopathy	1.42e-05	0.00472	CbGpPWpGaD
Riluzole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—dilated cardiomyopathy	1.39e-05	0.00462	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—RAC1—dilated cardiomyopathy	1.36e-05	0.00453	CbGpPWpGaD
Riluzole—CYP1A1—PPARA activates gene expression—AGT—dilated cardiomyopathy	1.28e-05	0.00425	CbGpPWpGaD
Riluzole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	1.25e-05	0.00416	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	1.22e-05	0.00406	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	1.22e-05	0.00406	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—ITGB1—dilated cardiomyopathy	1.21e-05	0.00402	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	1.16e-05	0.00387	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	1.16e-05	0.00387	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	1.13e-05	0.00378	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ANKRD1—dilated cardiomyopathy	1.11e-05	0.00371	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	1.08e-05	0.00359	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—RAF1—dilated cardiomyopathy	1.07e-05	0.00355	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	1.06e-05	0.00352	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—TAZ—dilated cardiomyopathy	1.05e-05	0.00349	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—CD36—dilated cardiomyopathy	1.03e-05	0.00343	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	1.01e-05	0.00338	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—RAC1—dilated cardiomyopathy	9.71e-06	0.00323	CbGpPWpGaD
Riluzole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	9.56e-06	0.00318	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—SDHA—dilated cardiomyopathy	9.47e-06	0.00315	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	9.23e-06	0.00307	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—RAF1—dilated cardiomyopathy	9.02e-06	0.003	CbGpPWpGaD
Riluzole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	8.61e-06	0.00287	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	7.78e-06	0.00259	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	7.78e-06	0.00259	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ANKRD1—dilated cardiomyopathy	7.54e-06	0.00251	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	7.41e-06	0.00247	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	7.41e-06	0.00247	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—TAZ—dilated cardiomyopathy	7.09e-06	0.00236	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—RAF1—dilated cardiomyopathy	6.44e-06	0.00214	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—SDHA—dilated cardiomyopathy	6.41e-06	0.00213	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—EGFR—dilated cardiomyopathy	6.19e-06	0.00206	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	4.81e-06	0.0016	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	4.52e-06	0.0015	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—EGFR—dilated cardiomyopathy	4.41e-06	0.00147	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—TNF—dilated cardiomyopathy	4.2e-06	0.0014	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	4.09e-06	0.00136	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.91e-06	0.0013	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3.81e-06	0.00127	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.43e-06	0.00114	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.34e-06	0.00111	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GPX1—dilated cardiomyopathy	2.57e-06	0.000857	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CD36—dilated cardiomyopathy	2.5e-06	0.000834	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.49e-06	0.00083	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.43e-06	0.000808	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—AGT—dilated cardiomyopathy	2.25e-06	0.000751	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.19e-06	0.000728	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GPX1—dilated cardiomyopathy	1.74e-06	0.00058	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CD36—dilated cardiomyopathy	1.7e-06	0.000565	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—AGT—dilated cardiomyopathy	1.53e-06	0.000508	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	1.11e-06	0.00037	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	1.08e-06	0.00036	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	9.73e-07	0.000324	CbGpPWpGaD
